Patents by Inventor DANIELA ENGLER-ANDERS

DANIELA ENGLER-ANDERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease
    Patent number: 11166986
    Abstract: The present invention is directed to polypeptides and compositions thereof useful for the prevention or treatment of an inflammatory bowel disease in particular Crohn's disease or ulcerative colitis (UC), and of coeliac disease. More particularly, the invention relates to agents and compositions thereof that useful for the prevention and treatment of hypersensitivity and/or hyperirritability of the colon and/or small intestine.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: November 9, 2021
    Assignee: UNIVERSITAT ZURICH
    Inventors: Anne Mueller, Daniela Engler-Anders
  • Tolerogenic compositions comprising and uses thereof
    Patent number: 9999660
    Abstract: The present invention is directed to polypeptides and compositions thereof useful for the prevention and treatment of allergic disorders, in particular atopic asthma. More particularly, the invention relates to tolerogenic agents and compositions thereof that are useful for the prevention and treatment of hypersensitivity to allergens, in particular strategies of desensitization to allergens.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: June 19, 2018
    Assignees: UNIVERSITAT ZURICH, LEIDEN UNIVERSITY MEDICAL CENTER
    Inventors: Anne Mueller, Daniela Engler-Anders, Christian Taube
  • USE OF HELIOCBACTER PYLORI EXTRACT FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASES AND COELIAC DISEASE
    Publication number: 20170007649
    Abstract: The present invention is directed to polypeptides and compositions thereof useful for the prevention or treatment of an inflammatory bowel disease in particular Crohn's disease or ulcerative colitis (UC), and of coeliac disease. More particularly, the invention relates to agents and compositions thereof that useful for the prevention and treatment of hypersensitivity and/or hyperirritability of the colon and/or small intestine.
    Type: Application
    Filed: January 30, 2015
    Publication date: January 12, 2017
    Inventors: ANNE MUELLER, DANIELA ENGLER-ANDERS
  • TOLEROGENIC COMPOSITIONS COMPRISING AND USES THEREOF
    Publication number: 20170007683
    Abstract: The present invention is directed to polypeptides and compositions thereof useful for the prevention of treatment of allergic disorders, in particular atopic asthma. More particularly, the invention relates to tolerogenic agents and compositions thereof that are useful for the prevention and treatment of hypersensitivity to allergens, in particular and/or strategies of desensitization to allergens.
    Type: Application
    Filed: January 30, 2015
    Publication date: January 12, 2017
    Inventors: Anne Mueller, Daniela Engler-Anders, Christian Taube